Company news

Hightide Therapeutics Inc news in 2024

Hightide Therapeutics Inc's news releases, calls and decks from 2024, newest first.

HighTide Therapeutics Presents Analyses of Phase 2a MASH Study at the 2024 International Liver Congress, Reinforcing and Further Characterizing the Efficacy and Safety of Berberine Ursodeoxcyholate...

June 7, 2024

Decks in 2024

Technical Presentation (September 2024)
Technical · 10 slides · September 2024